Structure | Chemical Name | CAS | MF |
|
8-METHOXY-QUINOLINE-2-CARBALDEHYDE
|
103854-64-4
|
C11H9NO2
|
|
1-BUTYL-6-OXO-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLIC ACID
|
103854-71-3
|
C9H12N2O3
|
|
1-(4-METHYLBENZYL)-2-THIOUREA
|
103854-74-6
|
C9H12N2S
|
|
4-(4-BROMOPHENYL)-1,2,3,6-TETRA HYDROPYRIDINE HYDROCHLORIDE
|
103855-00-1
|
C11H13BrClN
|
|
Alanine, N-glycyl-2-phenyl- (6CI)
|
103855-63-6
|
C11H14N2O3
|
|
DL-2,3-Dimethylphenylalanine
|
103855-82-9
|
C11H15NO2
|
|
CHEMBRDG-BB 4140266
|
103856-06-0
|
C11H15NO3
|
|
Benzimidazole, 1-ethyl-2-methyl-5-methylamino- (6CI)
|
103856-30-0
|
C11H15N3
|
|
Quinaldic acid, 5-methyl- (6CI)
|
103856-59-3
|
C11H9NO2
|
|
5-Methyl-1-(2-nitrophenyl)-1H-pyrazole-3-carboxylic acid
|
103856-74-2
|
C11H9N3O4
|
|
3-Azabicyclo[3.3.1]nonane,3-isopropyl-(6CI)
|
103856-87-7
|
C11H21N
|
|
2-(2-METHOXY-PHENYL)-PYRROLIDINE
|
103857-96-1
|
C11H15NO
|
|
Cinchoninic acid, 6-amino-2-methyl- (6CI)
|
103858-07-7
|
C11H10N2O2
|
|
2-Bromo-4,6-dimethylquinoline
|
103858-47-5
|
C11H10BrN
|
|
4-Bromoindole-2-carboxylic acid ethyl ester
|
103858-52-2
|
C11H10BrNO2
|
|
Ethyl 6-bromoindole-2-carboxylate
|
103858-53-3
|
C11H10BrNO2
|
|
RARECHEM AL BI 0374
|
103858-54-4
|
C11H10BrNO2
|
|
1H-INDOLE-3-CARBOXYLIC ACID,6-BROMO-ETHYL ESTER
|
103858-55-5
|
C11H10BrNO2
|
|
1H-INDOLE-3-CARBOXYLIC ACID,7-BROMO-,ETHYL ESTER
|
103858-56-6
|
C11H10BrNO2
|
|
4-DIISOPROPYLAMINO-1-BUTANOL
|
103859-38-7
|
C10H23NO
|
|
(3-METHOXY-4-PROPOXYPHENYL)METHANOL
|
103859-81-0
|
C11H16O3
|
|
4-(4'-Methoxyphenyl)-2-pyrrolidinone
|
103859-86-5
|
C11H13NO2
|
|
2-Pyridinecarbamicacid, 5-methyl-, ethyl ester, 1-oxide
|
103860-34-0
|
C9H12N2O3
|
|
3-Pyridinesulfonanilide(6CI)
|
103860-56-6
|
C11H10N2O2S
|
|
2,3-DIHYDROXYNAPHTHALENE-1,4-DICARBALDEHYDE
|
103860-60-2
|
C12H8O4
|
|
4-[2-CHLORO-4-(METHYLTHIO)PHENYL]-4-OXOBUTYRIC ACID
|
103860-95-3
|
C11H11ClO3S
|
|
1H-1,2,3-Triazole,5-ethoxy-1-p-tolyl-(6CI)
|
103861-17-2
|
C11H13N3O
|
|
2-(3-METHOXYPHENYL)PYRROLIDINE
|
103861-77-4
|
C11H15NO
|
|
5-BROMO-8-METHOXY-2-METHYL-QUINOLINE
|
103862-55-1
|
C11H10BrNO
|
|
4-CHLORO-6-ETHOXYQUINOLINE
|
103862-63-1
|
C11H10ClNO
|
|
2-Pyridinesulfonamide,N-phenyl-(9CI)
|
103863-00-9
|
C11H10N2O2S
|
|
1-ethoxy-4-nitroisoquinoline
|
103863-04-3
|
C11H10N2O3
|
|
4-PHENYLNICOTINIC ACID
|
103863-14-5
|
C12H9NO2
|
|
3-PHENYL-2-PYRIDINECARBOXYLIC ACID
|
103863-15-6
|
C12H9NO2
|
|
Carbamic acid, (3-amino-2-hydroxy-1-methylpropyl)-, 1,1-dimethylethyl ester
|
103865-02-7
|
C9H20N2O3
|
|
albothricin
|
103867-06-7
|
C20H36N8O7
|
|
SUCCINIC ANHYDRIDE-2,3-14C
|
103869-75-6
|
C4H4O3
|
|
5-Isoxazolecarboxamide,2,3-dihydro-N-methyl-3-oxo-(9CI)
|
103871-67-6
|
C5H6N2O3
|
|
5-Isoxazolecarboxamide,2,3-dihydro-N-(1-methylethyl)-3-oxo-(9CI)
|
103871-68-7
|
C7H10N2O3
|
|
3(2H)-Isoxazolone,5-[[(1-methylethyl)amino]methyl]-(9CI)
|
103871-71-2
|
C7H12N2O2
|
|
N-GLYCYLMUSCIMOL HYDROBROMIDE
|
103871-75-6
|
C6H10BrN3O3
|
|
2-Pyrrolidinone, 1-(3-phenylpropyl)-5-thioxo-
|
103872-62-4
|
C13H15NOS
|
|
3,6-Dihydroxy-2-[[2-(1,5-dimethyl-4-hexenyl)-5-methyl-5-hydroxy-2-cyclopentenyl]methyl]-2-cyclohexen-1-one
|
103873-57-0
|
|
|
3,6-Dihydroxy-2-[[5-[1,5-dimethyl-1,4-hexadienyl]-2-hydroxy-2-methylcyclopentyl]methyl]-2-cyclohexen-1-one
|
103873-58-1
|
|
|
Tricycloalternarene 2b
|
103873-59-2
|
|
|
6-[5-[(2,5-Dihydroxy-6-oxo-1-cyclohexenyl)methyl]-4-hydroxy-4-methyl-1-cyclopentenyl]-2-methyl-2-heptenal
|
103873-61-6
|
|
|
5-bromo-4-methylbenzo[d]thiazol-2-amine
|
103873-80-9
|
C8H7BrN2S
|
|
imidazolium-bis(imidazole)tetrachlororuthenate(III)
|
103875-27-0
|
|
|
titanocene bis(4-aminothiophenolate)
|
103875-37-2
|
C22H24Cl2N2S2Ti
|
|
4-(2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy)butyric acid
|
103876-49-9
|
C14H12N4O5
|
|
4-[2-oxo-3-(2H-tetrazol-5-yl)chromen-6-yl]oxybutanoic acid
|
103876-50-2
|
C14H12N4O5
|
|
6-((2-Oxo-3-(1H-tetrazol-5-yl)-2H-1-benzopyran-7-yl)oxy)hexanoic acid
|
103876-52-4
|
|
|
Hexanoic acid, 6-((2-oxo-3-(1H-tetrazol-5-yl)-2H-1-benzopyran-5-yl)oxy )-
|
103876-54-6
|
|
|
4-Hydroxy Omeprazole Sulfide
|
103876-98-8
|
C16H17N3O2S
|
|
2[(4-METHOXY-5-HYDROXYMETHYL-3-METHYLPYRID-2-YL)-METHYLTHIO]-5-METHOXYBENZIMIDAZOLE
|
103876-99-9
|
C17H19N3O3S
|
|
5-O-Desmethyl Omeprazole Sulfide
|
103877-02-7
|
C16H17N3O2S
|
|
(-)-N-METHYLPHYSOSTIGMINE
|
103877-07-2
|
C16H23N3O2
|
|
7-Chloro-1-cyclopropyl-1,4-dihydro-8-Methyl-4-oxo-3-quinolinecarboxylic Acid
|
103877-20-9
|
C14H12ClNO3
|
|
ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate
|
103877-51-6
|
C16H16ClNO3
|
|
2,5-DIFLUORO-4-METHYL-BENZOYLCHLORIDE
|
103877-56-1
|
C8H5ClF2O
|
|
2-Chloro-5-fluoro-4-methyl-benzoic acid
|
103877-61-8
|
C8H6ClFO2
|
|
Benzoyl chloride, 3,5-difluoro-4-methyl- (9CI)
|
103877-74-3
|
C8H5ClF2O
|
|
3-AMINO-5-FLUORO-4-METHYLBENZOIC ACID
|
103877-75-4
|
C8H8FNO2
|
|
3,5-Difluoro-4-methylbenzoic acid
|
103877-76-5
|
C8H6F2O2
|
|
2-Amino-5-fluoro-4-methyl-benzoic acid
|
103877-79-8
|
C8H8FNO2
|
|
2,5-Difluoro-4-methylbenzoic acid
|
103877-80-1
|
C8H6F2O2
|
|
3-Ethoxypicolinic acid
|
103878-09-7
|
C8H9NO3
|
|
4-Chloro-5-Methoxy-pyridine-2-carboxylic acid
|
103878-33-7
|
C7H6ClNO3
|
|
PYRIDINE-2-CARBOXYLIC ACID (2-AMINO-ETHYL)-AMIDE
|
103878-43-9
|
C8H11N3O
|
|
5-Bromothiazole-4-carboxylic acid
|
103878-58-6
|
C4H2BrNO2S
|
|
5-BroMo-2-chlorothiazole-4-carboxylic acid
|
103878-60-0
|
C4HBrClNO2S
|
|
N-(2-Aminoethyl)-5-chlor-2-pyridincarboxamid-hydrochlorid
|
103878-83-7
|
C8H10ClN3O.HCl
|
|
LAZABEMIDE
|
103878-84-8
|
C8H10ClN3O
|
|
dopamine-4-phosphate ester
|
103878-94-0
|
|
|
dopamine-3-phosphate ester
|
103878-95-1
|
C8H12NO5P
|
|
Fosopamine
|
103878-96-2
|
C9H14NO5P
|
|
3-CHLORO-4,5-DIFLUOROBENZONITRILE
|
103879-29-4
|
C7H2ClF2N
|
|
3,5-DICHLORO-4-FLUOROBENZONITRILE
|
103879-31-8
|
C7H2Cl2FN
|
|
N-(2-Aminoethyl)pyrazine-2-carboxamide
|
103879-45-4
|
C7H10N4O
|
|
5-METHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID
|
103879-58-9
|
C5H5NO3
|
|
4-Oxazolecarboxamide,N-(2-aminoethyl)-(9CI)
|
103879-63-6
|
C6H9N3O2
|
|
3-Isoxazolecarboxamide,N-(2-aminoethyl)-5-methyl-(9CI)
|
103879-76-1
|
C7H11N3O2
|
|
tyrosyl-cyclo(lysyl-glycyl-phenylalanyl-psi(thiomethylene)leucine)
|
103881-76-1
|
C32H45N5O5S
|
|
17α,21-Dihydroxypregn-1-ene-3,11,20-trione
|
103881-93-2
|
C21H28O5
|
|
BOC-P-IODO-DL-PHE-OH
|
103882-09-3
|
C14H18INO4
|
|
(1R)-5-Methoxy-1,2,3,4-tetrahydronaphthalen-1-aMine
|
103882-27-5
|
C11H15NO
|
|
gemcitabine
|
103882-84-4
|
C9H11F2N3O4
|
|
3'-Epi Gemcitabine
|
103882-85-5
|
C9H11F2N3O4
|
|
2'-Deoxy-2',2'-difluoroguanosine
|
103882-87-7
|
C10H11F2N5O4
|
|
EPICATECHIN-(4BETA->8:2BETA-O-7) CATECHIN
|
103883-03-0
|
C30H24O12
|
|
[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methanamine
|
103883-30-3
|
C6H13NO2
|
|
1H-Benzimidazole-4-carbonitrile,5-amino-1-methyl-(9CI)
|
103884-26-0
|
C9H8N4
|
|
1-METHYLCYCLOHEXYLFORMATE
|
103884-34-0
|
C8H14O2
|
|
5-Azidoalrestatin
|
103884-86-2
|
C14H8N4O4
|
|
9H-Purine-2,6-diamine, 9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-
|
103884-97-5
|
C10H13FN6O3
|
|
9-(2-Deoxy-2-fluoroarabinofuranosyl)guanine
|
103884-98-6
|
C10H12FN5O4
|
|
9H-Purine, 9-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-2,6-dichloro-
|
103884-99-7
|
C19H15Cl2FN4O5
|
|
Butanedioic acid, mono[2-[(1-oxo-2-propenyl)oxy]ethyl] ester, polymer with butyl 2-propenoate, ethenylbenzene and methyl 2-methyl-2-propenoate
|
103885-38-7
|
C29H40O10
|
|
(E)-2-((phenylimino)methyl)phenol
|
103886-92-6
|
C13H11NO
|
|
3,6-Dihydroxy-2-[[5-(2,6-dimethyl-1,5-heptadienyl)-3-methyl-3-hydroxyoxolan-2-yl]methyl]-2-cyclohexen-1-one
|
103886-93-7
|
|